Sign in

CIK 0000943819 · Large accelerated filer

RESMED INC

Sign in to watch
Tickers
RMD RSMDF
Exchange
NYSE, OTC
Industry
Surgical & Medical Instruments & Apparatus
FY end
Jun 30
Incorporated
DE
Entity type
operating
EIN
980152841
Phone
8587462400
Business address
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123

Securities

  • RMD ResMed Inc. Common Stock NYSE
  • RSMDF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,744,605
in 5 filings, $3.7M under 10b5-1 plans

Net −$3,744,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Farrell Michael J. −$3.4M Chairman and CEO sold 3% of stake
  2. FARRELL PETER C −$228K Director sold 2% of stake
  3. Rider Michael J −$102K Global General Counsel sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-15 Farrell Michael J. Chief Executive Officer Option exercise +5,675 $57.76 $328K 442,575
2023-03-15 Farrell Michael J. Chief Executive Officer Sale −5,675 $206.95 $1.2M 436,900
2023-03-15 Farrell Michael J. Chief Executive Officer Option exercise · ResMed Common Stock Options −5,675 48,865
2023-03-15 Douglas Robert Andrew President and COO Gift −1,919 259,526
2023-03-15 Douglas Robert Andrew President and COO Sale −1,500 $206.14 $309K 258,026
2023-03-03 PENDARVIS DAVID Chief Administrative Officer Sale −1,500 $216.69 $325K 94,172
2023-03-03 Ghoshal Kaushik President, SaaS Business Sale −1,000 $220.00 $220K 15,704
2023-02-17 Sandercock Brett Chief Financial Officer Sale −10,000 $215.22 $2.2M 106,880
2023-02-15 Douglas Robert Andrew President and COO Sale −1,500 $213.50 $320K 261,445
2023-02-15 Farrell Michael J. Chief Executive Officer Option exercise +5,675 $57.76 $328K 442,575
2023-02-15 Farrell Michael J. Chief Executive Officer Sale −5,675 $214.83 $1.2M 436,900
2023-02-15 Farrell Michael J. Chief Executive Officer Option exercise · ResMed Common Stock Options −5,675 54,540
2023-02-13 Sandercock Brett Chief Financial Officer Sale −4,000 $215.00 $860K 116,880
2023-02-03 PENDARVIS DAVID Chief Administrative Officer Sale −1,500 $224.50 $337K 95,672
2023-02-02 Drexler Karen Director Sale −594 $226.58 $135K 7,987
2023-01-17 Douglas Robert Andrew President and COO Sale −1,500 $220.43 $331K 226,208
2023-01-17 Farrell Michael J. Chief Executive Officer Option exercise +5,675 $57.76 $328K 442,575
2023-01-17 Farrell Michael J. Chief Executive Officer Sale −5,675 $224.36 $1.3M 436,900
2023-01-17 Farrell Michael J. Chief Executive Officer Option exercise · ResMed Common Stock Options −5,675 60,215
2023-01-03 PENDARVIS DAVID Chief Administrative Officer Sale −1,500 $210.07 $315K 97,172

Page 21 of 28 · 548 trades